Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis

By Heinz F.X.   Allison S.L.   Stiasny K.   Schalich J.   Holzmann H.   Mandl C.W.   Kunz C.  

Vaccine, Vol. 13, Iss. 17, 1995-12 ,pp. : 1636-1642

Elsevier

Access to resources Recommend Favorite

Vaccination against tick-borne encephalitis under therapeutic immunosuppression. Reduced efficacy in heart transplant recipients

By Dengler T.J.   Zimmermann R.   Meyer J.   Sack F.-U.   Girgsdies O.   Kubler W.E.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 867-874

Elsevier

Access to resources Recommend Favorite

Vaccination against tick-borne encephalitis (TBE): influence of simultaneous application of TBE immunoglobulin on seroconversion and rate of adverse events

By Hedenstrom M.v.   Heberle U.   Theobald K.  

Vaccine, Vol. 13, Iss. 8, 1995-06 ,pp. : 759-762

Elsevier

Access to resources Recommend Favorite

Vaccination against tick-borne encephalitis virus, a flavivirus, prevents disease but not infection, although viremia is undetectable

By Kreil T.R.   Maier E.   Fraiss S.   Attakpah E.   Burger I.   Mannhalter J.W.   Eibl M.M.  

Vaccine, Vol. 16, Iss. 11, 1998-07 ,pp. : 1083-1086

Elsevier

Access to resources Recommend Favorite

Evaluation of European tick-borne encephalitis virus vaccine against recent Siberian and far-eastern subtype strains

By Hayasaka D.   Goto A.   Yoshii K.   Mizutani T.   Kariwa H.   Takashima I.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4774-4779

Elsevier

Access to resources Recommend Favorite